Clinical Trial Update: Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of fentanyl buccal tablet for episodic breathlessness in cancer patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Dyspnea

Drugs mentioned

• Fentanyl Buccal Tablet (fentanyl buccal tablet)

Snippet

Sponsor: University of Cologne | Conditions: Cancer, Dyspnea, Paroxysmal | Phase 2 | Status: COMPLETED